Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Emergency pharmacist impact on health care-associated pneumonia empiric therapy.

DeFrates SR, Weant KA, Seamon JP, Shirakbari A, Baker SN.

J Pharm Pract. 2013 Apr;26(2):125-30. doi: 10.1177/0897190012451933. Epub 2012 Aug 23.

PMID:
22918891
2.
3.

Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study.

Mangino JE, Peyrani P, Ford KD, Kett DH, Zervos MJ, Welch VL, Scerpella EG, Ramirez JA; IMPACT-HAP Study Group..

Crit Care. 2011;15(1):R38. doi: 10.1186/cc9988. Epub 2011 Jan 25.

4.

Quality of care in elder emergency department patients with pneumonia: a prospective cohort study.

Caterino JM, Hiestand BC, Martin DR.

BMC Emerg Med. 2008 Apr 30;8:6. doi: 10.1186/1471-227X-8-6.

5.

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH.

Antimicrob Agents Chemother. 2007 Oct;51(10):3568-73. Epub 2007 Aug 6.

6.

Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.

Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Arch Intern Med. 2007 Jul 9;167(13):1393-9.

PMID:
17620533
7.
8.
9.

Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.

Lancaster JW, Lawrence KR, Fong JJ, Doron SI, Garpestad E, Nasraway SA, Devlin JW.

Pharmacotherapy. 2008 Jul;28(7):852-62. doi: 10.1592/phco.28.7.852.

PMID:
18576900
10.

A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.

Boyce JM, Pop OF, Abreu-Lanfranco O, Hung WY, Fisher A, Karjoo A, Thompson B, Protopapas Z.

Antimicrob Agents Chemother. 2013 Mar;57(3):1163-8. doi: 10.1128/AAC.01965-12. Epub 2012 Dec 17.

11.

Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study.

Falcone M, Corrao S, Licata G, Serra P, Venditti M.

Intern Emerg Med. 2012 Dec;7(6):523-31. doi: 10.1007/s11739-012-0795-8. Epub 2012 Jun 12.

PMID:
22688529
12.

Time to Guideline-Based Empiric Antibiotic Therapy in the Treatment of Pneumonia in a Community Hospital: A Retrospective Review.

Erwin BL, Kyle JA, Allen LN.

J Pharm Pract. 2016 Aug;29(4):386-91. doi: 10.1177/0897190014566303. Epub 2015 Jan 19.

PMID:
25601458
13.

Continuity of antibiotic therapy in patients admitted from the emergency department.

Shah MN, Schmit J, Croley WC, Meltzer D.

Ann Emerg Med. 2003 Jul;42(1):117-23.

PMID:
12827131
14.

Health care-associated pneumonia.

Amin A, Kollef MH.

Hosp Pract (1995). 2010 Jun;38(3):63-74.

PMID:
20499775
15.

Door-to-antibiotic time for pneumonia in a rural emergency department.

Anstett D, Smallfield A, Vlahaki D, Milne WK.

CJEM. 2010 May;12(3):207-11.

PMID:
20522285
16.
18.

Acute myocardial infarction complicated by hemodynamically unstable bradyarrhythmia: prehospital and ED treatment with atropine.

Swart G, Brady WJ Jr, DeBehnke DJ, MA OJ, Aufderheide TP.

Am J Emerg Med. 1999 Nov;17(7):647-52.

PMID:
10597081
19.

[The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia].

Taşbakan MS, Bacakoğlu F, Başoğlu OK, Gürgün A, Başarik B, Citim Tuncel S, Sayiner A.

Tuberk Toraks. 2011;59(4):348-54. Turkish.

20.

Supplemental Content

Support Center